Acute chest pain (ACP) is a common symptom that presents in a variety of clinical settings. Its broad differential diagnoses, ranging from benign to life-threatening conditions, necessitate a systematic diagnostic approach. This article aims to provide a comprehensive guide to evaluating ACP in clinical practice.
The initial assessment should focus on identifying life-threatening conditions, such as acute coronary syndrome (ACS), aortic dissection, and pulmonary embolism. A thorough history, physical examination, and 12-lead ECG are essential. High-risk features such as radiating pain, associated symptoms, and risk factors for cardiovascular disease should raise suspicion for ACS.
Following the initial assessment, further diagnostic testing may be required. Cardiac biomarkers, such as troponin, provide valuable information about myocardial injury. Imaging studies, like chest X-ray or CT angiography, can help diagnose other causes of ACP. However, these tests should be used judiciously, considering their risks and benefits.
Risk stratification is crucial in determining the disposition of patients with ACP. Several risk scores, including the HEART and GRACE scores, can be used to predict the risk of major adverse cardiac events. These scores can guide decisions regarding hospital admission and further testing.
Shared decision making is an important aspect of evaluating ACP. After discussing the diagnostic findings, potential risks, and management options, the clinician and patient can collaboratively make informed decisions about further management.
Evaluating ACP requires a systematic approach, including initial assessment, diagnostic testing, risk stratification, and shared decision making. By following these steps, clinicians can ensure a comprehensive evaluation of ACP, facilitating appropriate and timely management of this common clinical presentation.
1.
Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.
2.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
3.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
4.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
5.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
1.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
2.
Screening for Cancer-Related Neuromuscular Weakness: Clinical Approaches and Evidence-Based Strategies
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
5.
Exploring The Causes and Consequences of Low Transferrin Saturation
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation